Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Laurie Genest"'
Autor:
Tristan Rupp, Laurie Genest, David Babin, Christophe Legrand, Marion Hunault, Guillaume Froget, Vincent Castagné
Publikováno v:
Translational Oncology, Vol 20, Iss , Pp 101405- (2022)
The recent development of immunotherapy represents a significant breakthrough in cancer therapy. Several immunotherapies provide robust efficacy gains in a wide variety of cancers. However, in some patients the immune checkpoint blockade remains inef
Externí odkaz:
https://doaj.org/article/371165b4249048b6aa17da9e0464e942
Autor:
Tristan Rupp, Océane Pelouin, Laurie Genest, Christophe Legrand, Guillaume Froget, Vincent Castagné
Publikováno v:
Translational Oncology, Vol 14, Iss 1, Pp 100926- (2021)
Surgery followed by a chemotherapy agent is the first-line treatment for breast cancer patients. Nevertheless, new targets are required for women with triple-negative breast cancer (TNBC) in order to improve the treatment of this aggressive cancer su
Externí odkaz:
https://doaj.org/article/6e317bd985cc430d8276330d8c02dd02
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 15; Pages: 8192
New therapies are required for patients with non-small cell lung cancer (NSCLC) for which the current standards of care poorly affect the patient prognosis of this aggressive cancer subtype. In this preclinical study, we aim to investigate the effica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::505f7682917c9f5a91e054a925937670
Autor:
Tristan Rupp, Laurie Genest, David Babin, Christophe Legrand, Marion Hunault, Guillaume Froget, Vincent Castagné
Publikováno v:
Translational oncology. 20
The recent development of immunotherapy represents a significant breakthrough in cancer therapy. Several immunotherapies provide robust efficacy gains in a wide variety of cancers. However, in some patients the immune checkpoint blockade remains inef
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::725a209298c58d2ed251d1bfbbf326cc
https://pubmed.ncbi.nlm.nih.gov/35339889
https://pubmed.ncbi.nlm.nih.gov/35339889
Autor:
Tristan Rupp, Christophe Legrand, Marion Hunault, Laurie Genest, David Babin, Guillaume Froget, Vincent Castagné
Publikováno v:
Cancers; Volume 14; Issue 14; Pages: 3548
Ethical considerations, cost, and time constraints have highlighted the need to develop alternatives to rodent in vivo models for evaluating drug candidates for cancer. The tumor chicken chorioallantoic membrane (TCAM) model provides an affordable an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4dc9668728e1b378622744584047b15
https://doi.org/10.3390/cancers14143548
https://doi.org/10.3390/cancers14143548
Autor:
Guillaume Froget, Tristan Rupp, Vincent Castagné, Laurie Genest, Christophe Legrand, Océane Pelouin
Publikováno v:
Translational Oncology, Vol 14, Iss 1, Pp 100926-(2021)
Translational Oncology
Translational Oncology
Highlights • Fingolimod represses triple negative breast cancer cells survival in vitro by inducing cell apoptosis. • Fingolimod represses triple negative breast cancer progression in orthotopic graft murine in vivo models. • Fingolimod repress
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf7a9c390ce1a145fe00e935bb7ba50f
https://doi.org/10.1016/j.tranon.2020.100926
https://doi.org/10.1016/j.tranon.2020.100926